Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$169K Buy
1,408
+1,356
+2,608% +$157K 0.15% 105
2025
Q4
$5.47K Sell
52
-2,771
-98% -$260K 0.01% 144
2025
Q3
$237K Sell
2,823
-70
-2% -$5.77K 0.03% 207
2025
Q2
$229K Sell
2,893
-179
-6% -$14.2K 0.03% 189
2025
Q1
$276K Buy
3,072
+543
+21% +$50.7K 0.04% 144
2024
Q4
$252K Buy
2,529
+379
+18% +$39.1K 0.05% 142
2024
Q3
$244K Sell
2,150
-93
-4% -$11K 0.05% 124
2024
Q2
$278K Buy
2,243
+572
+34% +$73.7K 0.07% 101
2024
Q1
$220K Buy
+1,671
New +$206K 0.05% 125

Other funds holding MRK

Fountainhead AM's MRK Position: Q1 2026 in Review

Fountainhead AM increased its Merck (MRK) stake by 2,608% in Q1 2026, buying an estimated $157K and bringing the position to 1,408 shares worth $169K. The position accounts for 0.15% of the portfolio, ranked #105.

Fountainhead AM first reported a position in MRK in Q1 2024 and has held it in 9 quarters since. The position peaked at $278K in Q2 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Fountainhead AM held 1,408 shares of Merck worth $169K as of Q1 2026.
  • Fountainhead AM bought 1,356 Merck shares in Q1 2026, an estimated $157K.
  • Merck made up 0.15% of Fountainhead AM's portfolio in Q1 2026, its #105 holding.
  • Fountainhead AM first reported a position in Merck in Q1 2024 and has held it in 9 quarters since.
  • Fountainhead AM's Merck position peaked at $278K in Q2 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Fountainhead AM's 13F filing for Q1 2026, filed 11 May 2026.